Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Paracetamol fast dissolution · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Fast dissolution suspension | EXPERIMENTAL | - |
| Medium dissolution suspension | EXPERIMENTAL | - |
| Slow dissolution suspension | EXPERIMENTAL | - |
| Marketed suspension | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Paracetamol fast dissolution suspension | DRUG | - |
| Paracetamol medium dissolution suspension | DRUG | - |
| Paracetamol slow dissolution suspension | DRUG | - |
| Paracetamol | DRUG | - |
Inclusion Criteria: * Healthy volunteer * Body Mass Index between 19.0 - 28.0 (kg/m2) inclusive
Paracetamol fast dissolution is an investigational small molecule being developed by GSK plc for use in healthy subjects. It is a paracetamol formulation designed for fast dissolution. The drug is currently in Phase 1 clinical development, meaning it is still being studied and is not yet approved for any use.
Paracetamol fast dissolution is being studied for use in healthy subjects. It is intended as a paracetamol formulation, which is commonly used for pain relief and fever reduction. However, the specific indication for this fast dissolution version has not been established beyond its testing in healthy volunteers.
Paracetamol fast dissolution is developed by GSK plc, a global pharmaceutical company listed on the stock exchange under the ticker GSK. GSK is conducting clinical research on this investigational paracetamol formulation.
Paracetamol fast dissolution is in Phase 1 clinical development. It has completed one Phase 1 trial, which was a pharmacokinetic study. The drug remains investigational and has not received regulatory approval.
Paracetamol fast dissolution has one completed clinical trial, NCT01476215, titled "A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions." This Phase 1 study enrolled 18 healthy male subjects in the United States and was active-controlled.
Paracetamol fast dissolution is a formulation of paracetamol, the common pain reliever and fever reducer. It is designed to dissolve quickly, which may affect how rapidly it is absorbed. However, it is an experimental formulation and is not the same as standard marketed paracetamol products.